XBiotech Stock Price

0.00 (0.0%)
Upgrade to Real-Time
Afterhours (Closed)
Volume 0
Bid Price 3.55
Ask Price 3.65
News -
Day High


52 Week Range


Day Low
Company Name Stock Ticker Symbol Market Type
XBiotech Inc XBIT NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 3.62 20:00:00
Open Price Low Price High Price Close Price Prev Close
Trades Volume Avg Volume 52 Week Range
0 0 - 3.55 - 16.47
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 3.62 USD


Draw Mode:

XBiotech Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 110.19M 30.44M 23.59M $ 18.39M $ -17.42M -0.58 -4.10
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 100.00k 22.50%

more financials information »

XBiotech News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical XBIT Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week3.703.773.553.6337,496-0.08-2.16%
1 Month4.054.3553.553.9542,213-0.43-10.62%
3 Months5.725.723.554.6151,612-2.10-36.71%
6 Months9.199.273.555.9297,556-5.57-60.61%
1 Year13.0016.473.558.1881,610-9.38-72.15%
3 Years9.2033.203.5516.16184,716-5.58-60.65%
5 Years4.3933.202.1313.47154,587-0.77-17.54%

XBiotech Description

XBiotech Inc is a United States based clinical-stage biopharmaceutical company. It is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-IL-1 a therapeutic antibody as a treatment for cancer. Geographically, all of its operations are in the United States.

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now